YKL-40 and MMP-9 as Serum Markers for Patients with Primary Central Nervous System Lymphoma

OBJECTIVE: To evaluate YKL-40 and MMP-9 proteins as tumor biomarkers in serum samples from patients with primary central nervous system lymphoma (PCNSL). METHODS: In this prospective longitudinal study, serum samples from consecutive patients with histologically confirmed PCNSL were collected concur...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Neurol
Asıl Yazarlar: Hottinger, Andreas F., Iwamoto, Fabio M., Karimi, Sasan, Riedel, Elyn, Dantis, Jocelynn, Park, Joseph, Panageas, Katherine S., Lassman, Andrew B., Abrey, Lauren E., Fleisher, Martin, Holland, Eric C., DeAngelis, Lisa M., Hormigo, Adília
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295085/
https://ncbi.nlm.nih.gov/pubmed/21391238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22360
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller